Clinical Trials Logo

Metastatic Chordoma clinical trials

View clinical trials related to Metastatic Chordoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT05041127 Recruiting - Chordoma Clinical Trials

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Start date: May 27, 2022
Phase: Phase 2
Study type: Interventional

This is a multicenter, single arm, phase 2 study designed to evaluate the efficacy and safety of cetuximab for the treatment of advanced (unresectable)/metastatic, chordoma. The target patient population will be any chordoma patient 18 years of age with locally unresectable disease or metastatic disease.

NCT ID: NCT03623854 Active, not recruiting - Chordoma Clinical Trials

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Start date: April 3, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well nivolumab and relatlimab work in treating participants with chordoma that has spread to other places in the body. Monoclonal antibodies, such as nivolumab and relatlimab, may interfere with the ability of tumor cells to grow and spread.